Actuate Therapeutics (ACTU) said Tuesday it will join the Russell 2000 Index effective after the opening of markets on Dec. 23.
The company said it will be added to the index as part of the planned Q4 initial public offering additions.
Shares of Actuate Therapeutics rose 9.3% in premarket activity Tuesday.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments